Showing results (401-410 of 1,352) with videos related to

Sort By:
Pageof 136
Swiss Medical Weekly|February 23, 2008
Device-less patent foramen ovale closure by radiofrequency thermal energyNazan B Walpoth, Kathrin Habermacher, Igal Moarof, et al.
The American Journal of Cardiology|January 31, 2007
Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosisPeter Wenaweser, Stephan Windecker, Michael Billinger, et al.
International Journal of Cardiology|January 20, 2007
Local vascular dysfunction after coronary paclitaxel-eluting stent implantationMario Togni, Lorenz Räber, Rosangela Cocchia, et al.
European Heart Journal|January 14, 2016
Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndromeAndreas W Schoenenberger, Dragana Radovanovic, Stephan Windecker, et al.
Plos One|September 22, 2017
Sports engagement and age at first myocardial infarction in men under 55 years of ageChristoph Janggen, Christoph Gräni, Jonas Brunner, et al.
The Journal of Invasive Cardiology|June 2, 2017
Propensity-Score Matched Comparison of the Cera PFO Occluder With the Amplatzer PFO Occluder for Percutaneous Closure of Patent Foramen Ovale Without Echocardiographic GuidanceMirjam Ulmi, Fabien Praz, George C M Siontis, et al.
Circulation|July 1, 2004
Deleterious effect of coronary brachytherapy on vasomotor response to exerciseMario Togni, Stephan Windecker, Peter Wenaweser, et al.
Arquivos Brasileiros De Cardiologia|May 16, 2012
Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillationEnio Eduardo Guérios, Michael Schmid, Steffen Gloekler, et al.
Circulation. Cardiovascular Interventions|September 8, 2020
Comparison of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents and Thin, Durable-Polymer Everolimus-Eluting Stents in Calcified or Small Vessel LesionsKazuhiro Dan, Hector M Garcia-Garcia, Paul Kolm, et al.
European Heart Journal|October 26, 2017
Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trialsKonstantinos C Koskinas, George C M Siontis, Raffaele Piccolo, et al.
Pageof 136